News
2d
MedPage Today on MSNPulmonary Rehabilitation for COPD Pushes ForwardHome-based pulmonary rehabilitation has been slowly gaining momentum for chronic obstructive pulmonary disease (COPD), but ...
2don MSN
Walking is a fundamental activity for maintaining health. While numerous studies have assessed how much people with chronic ...
2d
MedPage Today on MSNEasing Airway Assaults in COPDFor COPD patients, the adage holds true: "the first way to get out of a hole is to quit digging one," said Christopher Mosher ...
5d
Clinical Trials Arena on MSNSanofi and Regeneron report results from two Phase III trials of COPD treatmentSanofi and Regeneron have reported that the Phase III AERIFY-1 trial of the fully human monoclonal antibody itepekimab.
A Winnipeg woman who was given a life expectancy of six months after cancer metastasized from her lungs to her brain, liver ...
Canadian wildfire smoke has entered the Upper Midwest and poses significant health impacts in the hardest-hit areas.
Yet thanks to a new hospital-based educational and advocacy initiative for COPD patients, Croswell has been managing well at ...
Researchers warn of increased cannabis use among older US adults, as experts link it to health risks and complications in ...
(Reuters) -Regeneron shares fell nearly 18% on Friday after its experimental drug for patients with a type of lung condition ...
Topline results were announced from two phase 3 trials evaluating itepekimab in former smokers with inadequately controlled COPD.
People who lost weight in midlife were less likely to experience heart attacks, strokes, cancer, asthma or chronic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results